Abbott Laboratories ABT shares are trading at a discount to the Zacks Medical Products industry. Its trailing 12-month price-to-book value of 4.91X is significantly lower than the industry average of ...

Investors interested in Medical stocks should always be looking to find the best-performing companies in the group. Abbott (ABT) is a stock that can certainly grab the attention of many investors ...

This has lagged the Medical sector's loss of 0.78% and the S&P 500's gain of 3.6% in that time. Analysts and investors alike will be keeping a close eye on the performance of Abbott in its ...

Bernstein analyst Lee Hambright lowered the firm’s price target on Abbott (ABT) to $135 from $138 and keeps an Outperform rating on the shares ...

I think the evidence shows that Abbott is one of a handful of big pharma companies on the cutting edge of critical medical solutions for the future, and backed up by the track record of the past.

The ABBOTT PRISM System is an automated immunoassay analyzer designed to perform Chemiluminescent immunoassay (ChLIA) technology. The ABBOTT PRISM performs batch/continuous access and STAT ...